uce
ProgressImage ProgressImage
Cohance Lifesciences Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code 543064 border-img ISIN Demat INE03QK01018 border-img Book Value 60.86 border-img NSE Symbol COHANCE border-img Div & Yield % 0 border-img Market Cap ( Cr.) 34972.38 border-img P/E 99.04 border-img EPS 9.23 border-img Face Value 1
Quarters
ParticularsJun 2025
()
Mar 2025
()
Dec 2024
()
Gross Sales483.58768.57284.27
Other Operating Income0.000.000.00
Other Income 13.108.1915.50
Total Income496.68776.76299.77
Total Expenditure 387.48561.58171.05
PBIDT109.20215.18128.72
Interest 6.807.002.62
PBDT102.40208.18126.10
Depreciation31.3642.5814.88
Tax18.1530.7441.79
Fringe Benefit Tax0.000.000.00
Deferred Tax0.3212.09-14.24
Reported Profit After Tax52.57122.7783.67
Extra-ordinary Items -5.99-11.700.00
Adjusted Profit After Extra-ordinary item58.56134.4783.67
    
EPS (Unit Curr.)1.383.223.29
EPS (Adj) (Unit Curr.)1.383.223.29
Calculated EPS (Unit Curr.)2.064.823.29
Calculated EPS (Adj) (Unit Curr.)2.064.823.29
Calculated EPS (Ann.) (Unit Curr.)8.2619.2913.15
Calculated EPS (Adj) (Ann.) (Unit Curr.)8.2619.2913.15
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity25.4625.4625.46
Reserve & Surplus0.000.000.00
Face Value1.001.001.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)22.5828.0045.28
PBDTM(%)21.1827.0944.36
PATM(%)10.8715.9729.43
x
x
×
Let's Chat
close
refresh